Pharmatica

In this special Scientific Council Spotlight episode of The Discovery Loop podcast, host Shubhangi Dua, Journalist, Podcast Producer and Podcast Host at Pharmatica.io, sits down with Deepankar Nayak, the CEO of Deep Longevity. Nayak also serves on Pharmatica’s Scientific Council.

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

“The pharma industry is beginning to look at biological age as a surrogate endpoint to improve clinical trials."

In the recent episode of The Clinical Compass podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist, is joined by Dr Amber Hill, Founder and CEO of Research Grid. They talk about how pharmaceutical companies and their leaders should approach the use of AI in clinical trials.

In the recent episode of The Discovery Loop podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io, sat down with Diana Andrade, Founder & Managing Director at RD Privacy and Data Protection Officer (DPO) for Biopharma and Life Sciences. They talk about the current state of data protection regulations and how enterprises can innovate responsibly.

In the recent episode of The Chain Reaction podcast, Nour AlSaleh, Founder and CEO of Veragence Pharma Consultancy, sat down with host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io and EM360Tech. AlSaleh shares her expertise on maintaining data integrity in this new era of AI and changing policies.

Kate O’Reilly, President & Chair of the Healthcare Businesswomen’s Association (HBA) Dublin-Ireland Chapter & Healthcare Transformation Partner at Roche, discusses AI in pharma, patient engagement, and the future of healthcare innovation.

In the recent episode of the Digital Pulse podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist, sat down with Lara Masad, an AI and Data Innovation independent consultant, to clarify the key distinctions in AI and machine learning models. Furthermore, Masad explains how pharmaceutical companies benefit from using AI models.

Trisha Pillay speaks with Judit Mora, CEO of Nuumad, on Digital Pulse discussing pharmacy innovation, market access barriers, and new models for faster patient access to healthcare.

Trisha Pillay speaks with Dineshree Naiker, co-founder of Umsebe Healthcare, on Chain Reaction discussing regulatory leadership, pharmaceutical supply chains, and improving patient access to medicines.

Exclusive Pharmatica Content

Explore expert-led podcasts, pharmaceutical intelligence, life sciences insights and research-driven analysis from leading industry voices. Pharmatica delivers trusted biotech news, drug development trends and commercial intelligence for professionals across the pharmaceutical sector.

Shubhangi Dua

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

“The pharma industry is beginning to look at biological age as a surrogate endpoint to improve clinical trials."

Nicole Dale

Can AI and Machine Learning in Sterile Manufacturing Improve Quality?

Pharmatica image representing AI and machine learning in sterile pharmaceutical manufacturing. The image shows precision glass ampoules with a digital data mesh overlay, symbolising AI-driven quality and contamination detection.

Discover how AI/ML in sterile pharmaceutical manufacturing enables predictive maintenance, quality control, contamination detection, and intelligent GMP operations.

Nicole Dale

What Drives Pharmaceutical R&D Success? New Benchmarking Reveals Why Some Drug Pipelines Outperform Others

Pharmatica image showing a pharmaceutical R&D portfolio management meeting reviewing drug discovery pipeline progression, translational science, and pharmaceutical R&D success rates using evidence-based portfolio strategy.

Explore new benchmarking research on pharmaceutical R&D success rates, revealing why some drug pipelines consistently achieve higher approval rates than others.

Nicole Dale

Modular Pharma Factories: The Next Step for Continuous Manufacturing?

Pharmatica image showing modular pharmaceutical manufacturing using continuous pharmaceutical manufacturing processes, interconnected production modules, and Process Analytical Technology to improve flexible drug manufacturing.

Discover how modular pharmaceutical manufacturing and continuous production could improve flexibility, resilience, and efficiency across modern pharmaceutical operations.

Nicole Dale

Foundational AI In Cell and Gene Therapy Development Success

Pharmatica image representing AI in cell and gene therapy development success through improving drug discovery, viral vector engineering, manufacturing, and predictive quality control.

Discover why AI in cell and gene therapy is necessary for successful development by improving drug discovery, viral vector engineering, manufacturing, and quality control.

Nicole Dale

Success for Non-Animal Testing of Preclinical Toxicity?

Pharmatica hyper-realistic image of a human organ-on-chip platform with cultured cells used for non-animal testing in drug discovery in order to determine preclinical toxicity in a pharmaceutical research laboratory.

Can non-animal testing methods be used in preclinical drug discovery? Here is what the evidence is for their accuracy and limits assessing preclinical toxicity.

Nicole Dale

Why CMC Strategy Defines Cell and Gene Therapy Success

Pharmatica image of a modern cell and gene therapy manufacturing facility supporting advanced CMC strategy through GMP production, digital process monitoring, pharmaceutical quality systems, and bioprocess innovation.

Cell and gene therapy CMC strategies, quality systems, and manufacturing innovation are critical to advanced therapy development and determine scalability.

Nicole Dale

Great Drug Discovery Starts with Great Scientists

Pharmatica image of a modern pharmaceutical research laboratory representing drug discovery scientists using computational biology, structural biology, medicinal chemistry, and AI-assisted therapeutic research.

Learn how drug discovery scientists are evolving alongside AI, computational biology, and multidisciplinary research to accelerate therapeutic innovation.

Nicole Dale

GLP-1 Drug Discovery Success Transformed Pharmaceutical R&D

Pharmatica photorealistic illustration of GLP-1 drug discovery showing peptide molecules, metabolic signalling pathways, and obesity treatment research in a modern pharmaceutical laboratory.

From gut hormones to global therapeutics, GLP-1 drug discovery transformed obesity treatment through peptide engineering and incretin biology translation.

Nicole Dale

Can Deep Learning Survive the Precision Medicine Paradox?

High‑resolution laboratory data visualisation screen showing molecular structures, DNA helix, and genomic charts in green and sunshine yellow against a clean white background, symbolising precision medicine and advanced drug discovery.

As precision medicine narrows patient cohorts to rare‑disease scales, deep learning models face a paradox of data scarcity and overfitting that threatens the future of clinical AI.

Nicole Dale

Genomic Governance Ensures Equity at the Core of Drug Discovery

Scientists analysing diverse genomic datasets to support genomic equity, AI-driven drug discovery, and precision medicine in pharmaceutical research.

Discover why genomic equity is essential for reliable AI-driven drug discovery, precision medicine, and building more representative pharmaceutical innovation.

Nicole Dale

AAV Vector Manufacturing: Solving Gene Therapy's Bottleneck

Scientist’s gloved hands handling a vial and pipette in a bright laboratory with a glowing DNA helix and AAV capsid, representing advanced AAV vector manufacturing and gene therapy process development.

Discover how innovations in AAV vector manufacturing are improving scalability, quality, and commercial readiness for next-generation gene therapies.

Content type

Topic

Articles, expert interviews, and insights from life sciences leaders

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

Can AI and Machine Learning in Sterile Manufacturing Improve Quality?

What Drives Pharmaceutical R&D Success? New Benchmarking Reveals Why Some Drug Pipelines Outperform Others

Modular Pharma Factories: The Next Step for Continuous Manufacturing?

Foundational AI In Cell and Gene Therapy Development Success

Success for Non-Animal Testing of Preclinical Toxicity?

Why CMC Strategy Defines Cell and Gene Therapy Success

Great Drug Discovery Starts with Great Scientists

GLP-1 Drug Discovery Success Transformed Pharmaceutical R&D

Can Deep Learning Survive the Precision Medicine Paradox?

Genomic Governance Ensures Equity at the Core of Drug Discovery

AAV Vector Manufacturing: Solving Gene Therapy's Bottleneck